| Posted
5-16-08
Study Launched
to Uncover the Mysteries of Chronic Fatigue Syndrome
(CDC) -- Researchers
from the Centers for Disease Control and Prevention (CDC) and Emory University
School of Medicine in Atlanta recently launched the most comprehensive
population-based clinical study to date of patients with chronic fatigue
syndrome (CFS). The study includes about 90 patients from Atlanta who
will participate in the three-day in-patient clinical trial. Researchers
hope results from the study will help them better understand how the syndrome
affects people and lead to more successful treatment.
"We're learning
more about the complexities of the illness that is chronic fatigue syndrome,"
said William C. Reeves, M.D., Chief of the Chronic Fatigue Syndrome Research
Program at CDC. "Launching this research study with Emory will help
us draw a clearer picture of how CFS affects people that ultimately could
lead to more effective treatment of patients with CFS."
Each designated participant
will spend three days at Emory University Hospital General Clinical Research
Center (GCRC). Participants will undergo repeated blood draws and salivary
sampling in addition to computerized testing and functional Magnetic Resonance
Imaging (fMRI) of the brain. The study is planned to be completed within
a year.
CFS, a condition characterized
by fatigue, memory problems, and pain, may be more widespread than once
thought. Experts estimate that between one and four million people in
the United States may suffer from CFS. Unfortunately, an estimated 80
percent of all CFS patients have not yet been diagnosed by a medical provider.
The CDC-Emory study
is designed to evaluate mechanisms of the illness with an emphasis on
alterations in the regulation of hormones and the immune system as well
as alterations in the brain circuits involved in cognitive function and
mental fatigue. The molecular and genetic aspects of these alterations
will also be explored.
"We believe this
research will lead us to a better understanding of the causes of CFS,
both from a psychological and biological standpoint," says Andrew
Miller, M.D., Timmie Professor of Psychiatry and Behavioral Sciences at
Emory and Emory principal investigator of the study. "We believe
that this study will open doors that may lead us to better ways of diagnosing
and treating CFS in the future."
CFS – The Larger
Public Health Impact
It is estimated that only half of CFS patients have sought medical attention
and fewer than one in five have been diagnosed and treated. This is a
particular source of concern since early treatment could be associated
with a significantly higher rate of recovery. Often, patients may report
symptoms like being frequently exhausted, or having difficulty sleeping
and concentrating, which may be linked to many other causes.
Dr. Reeves said, "CFS
is often difficult to diagnose and physicians rely on patients reporting
symptoms to identify the illness. There is no disease specific laboratory
test for CFS, and the diagnosis is often made through a process of eliminating
other causes that may explain the patients' signs and symptoms."
CFS occurs most frequently
in women ages 40-60, but affects all races, sexes, and age groups, and
can be as disabling as multiple sclerosis and chronic obstructive pulmonary
disease. The condition can also take a tremendous personal and social
toll on patients and their families, with a quarter of those affected
by CFS either unemployed or on disability assistance.
"Our economic
impact studies show that a family in which someone has CFS could forego
up to $20,000 a year in annual earnings and wages, and that a quarter
of them are either on disability or out of work following the illness,"
explains Reeves. "It is a serious public health problem."
If you think you or
someone you know might be suffering from CFS, consult a health care professional
to learn more about options that are available for you. For more information
on CFS, visit www.cdc.gov/cfs.
Milestones of Previous CFS Studies
• CDC estimates
that 2.5% of Georgians ages 18-59 years suffer from chronic fatigue syndrome.
This represents a six- to ten-fold higher prevalence than previous estimates
from other areas.
• CDC estimates
that the average family in which a member suffers from CFS foregoes $20,000
in annual earnings and wages, nearly half the median US household income.
• CDC studies
reveal that early life stress and accumulated lifetime stress are strongly
and significantly associated with CFS. The current study at Emory Hospital
will further clarify these findings.
• CDC research
reveals that abnormally low morning concentrations of the hormone cortisol
may be correlated with more severe fatigue in CFS patients, especially
in women.
• CDC research
has demonstrated that multiple types of early childhood trauma are important
risk factors for CFS.
• CDC has conducted
numerous studies to better understand the symptoms which would be included
in the definition of chronic fatigue syndrome. Ultimately, this research
has provided a formal case definition for CFS and provides clinicians
a guide for diagnosing patients.
Additional Information
CDC has a comprehensive provider education program that includes outreach
nationally at conferences, grand rounds, and through on-line continuing
education. This outreach is aimed at aiding providers in the diagnosis,
management, and treatment of CFS.
CDC purposely attempts to publish research on CFS in open-access journals
to aid the public, patients, and providers in obtaining the most up-to-date
information on this illness. For more information on the studies being
conducted by CDC on chronic fatigue syndrome and the resulting research,
please see the CFS website: http://www.cdc.gov/cfs/cfsresearch.htm.
|